D.Western Therapeutics Institute, Inc. Logo

D.Western Therapeutics Institute, Inc.

4576 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
名古屋市中区錦一丁目18番11号
Sector:
Health Care
Industry:
Pharmaceuticals

Description

D.Western Therapeutics Institute, Inc. is a pioneering biotech company established in Japan with the mission of developing innovative new drugs to enhance global health. Focused on drug discovery and development, DWTI aims to provide patients with therapies that surpass conventional treatments in efficacy and benefits. The company leverages its proprietary compound library and specializes in inhibitors, particularly targeting protein kinases, to create groundbreaking therapies. Committed to advancing healthcare, DWTI promotes a unique approach that emphasizes the importance of innovation in drug development, ensuring that patients receive the most effective treatments available. Through its dedicated efforts, D.Western Therapeutics Institute strives to make a significant impact in the pharmaceutical industry.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-15 08:30
Prospectus
有価証券届出書(組込方式)
Japanese 540.8 KB
2025-03-26 01:26
Inside Information Statement
臨時報告書
Japanese 25.8 KB
2025-03-25 07:31
Regulatory News Service
確認書
Japanese 8.2 KB
2025-03-25 07:30
Internal Control over Financial Reporting
内部統制報告書-第27期(2024/01/01-2024/12/31)
Japanese 21.5 KB
2025-03-25 07:30
Annual Report
有価証券報告書-第27期(2024/01/01-2024/12/31)
Japanese 1.1 MB
2025-01-16 07:34
Inside Information Statement
臨時報告書
Japanese 18.4 KB
2025-01-10 02:55
Inside Information Statement
臨時報告書
Japanese 21.1 KB
2024-08-09 08:35
Regulatory News Service
確認書
Japanese 8.2 KB
2024-08-09 08:34
Interim Report
半期報告書-第27期(2024/01/01-2024/12/31)
Japanese 219.2 KB
2024-06-07 08:31
Inside Information Statement
臨時報告書
Japanese 19.3 KB
2024-05-17 08:01
Prospectus
有価証券届出書(組込方式)
Japanese 328.7 KB
2024-05-13 08:32
Regulatory News Service
確認書
Japanese 8.1 KB
2024-05-13 08:31
Quarterly Report
四半期報告書-第27期第1四半期(2024/01/01-2024/03/31)
Japanese 135.5 KB
2024-03-28 01:39
Inside Information Statement
臨時報告書
Japanese 20.6 KB
2024-03-27 07:03
Regulatory News Service
確認書
Japanese 8.2 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nippon Shinyaku Co.,Ltd. Logo Nippon Shinyaku Co.,Ltd. Japan 4516
Noile-Immune Biotech Inc. Logo Noile-Immune Biotech Inc. Japan 4893
Novartis AG Logo Novartis AG Switzerland NOVN
Nur Ink Innovations Ltd. Logo Nur Ink Innovations Ltd. Israel NURI
Nxera Pharma Co., Ltd. Logo Nxera Pharma Co., Ltd. Japan 4565
ObsEva SA Logo ObsEva SA Switzerland OBSN
ODI Pharma AB Logo ODI Pharma AB Sweden ODI
Oncolys BioPharma Inc. Logo Oncolys BioPharma Inc. Japan 4588
OncoTherapy Science, Inc. Logo OncoTherapy Science, Inc. Japan 4564
OncoZenge AB Logo OncoZenge AB Sweden ONCOZ